In this post, Editor and Senior Writer Julie Dibble demystifies market access as she examines its impact on major stakeholders in the healthcare chain.
In this post, process manager Stephanie Kesterson reviews the features you should consider when looking for the best tool to manage your work.
In this post, senior instructional designer Lea Binderup explains why it’s tricky to define her role—and how IDs can be crucial to a project’s success.
In this post, medical writer and editor Marian Mostovy reviews key takeaways from the AMA’s updated guidelines on race and ethnicity and discusses their bearing on life sciences sales, marketing, and training communications.
In this post, Victoria Sahadevan Fossland, MD, a general surgeon and medical writer, provides an overview of COVID-19 variants being monitored in the US and globally, reviews whether available COVID-19 vaccines are effective for these variants, and examines how scientists are preparing for future COVID strains.
In this post, medical writer Jim Kesslick examines the promises and challenges of CGTs and their potential impact on life sciences companies.
In this post, Encompass’s senior director of media production Mary Barlow examines ways the pandemic has spurred support from payers and providers for this holistic approach to care as well as how this trend could impact life sciences companies.
In this post, medical writer and editor Marian Mostovy spotlights key changes to reference citations and provides tips on how to get the most from this guide, considered the holy grail for medical writers.
In this post, pharmaceutical writer Jessica Meth examines the reasons behind the growing use of prior authorizations and provides tips to help ensure success when marketing products in today’s highly restrictive environment.
By Victoria Sahadevan Fossland, Medical Writer Information and data regarding the COVID-19 pandemic and a COVID-19 vaccine is changing rapidly. The information contained here is current as of August 11, 2020. Normally, vaccines require years from development to approval by the US Food and Drug Administration (FDA).1 Many people are wondering…
